- Report
- June 2026
- 194 Pages
Global
From €3207EUR$3,545USD£2,746GBP
€3563EUR$3,939USD£3,052GBP
- Report
- February 2026
- 250 Pages
Global
From €4062EUR$4,490USD£3,478GBP
- Report
- July 2026
- 193 Pages
Global
From €5292EUR$5,850USD£4,532GBP
- Report
- May 2026
- 185 Pages
Global
From €4071EUR$4,500USD£3,486GBP
- Report
- January 2026
- 180 Pages
Global
From €4071EUR$4,500USD£3,486GBP
- Report
- May 2026
- 100 Pages
Global
From €2442EUR$2,699USD£2,091GBP
- Report
- April 2026
- 139 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- December 2025
- 150 Pages
Global
From €4388EUR$4,850USD£3,757GBP
- Report
- January 2026
- 207 Pages
Latin America
From €2262EUR$2,500USD£1,937GBP
- Report
- February 2026
- 250 Pages
Global
From €4062EUR$4,490USD£3,478GBP
- Report
- May 2026
- 150 Pages
Global
From €5383EUR$5,950USD£4,609GBP
- Report
- April 2026
- 180 Pages
Global
From €5383EUR$5,950USD£4,609GBP
- Report
- January 2026
- 150 Pages
Global
From €5383EUR$5,950USD£4,609GBP
- Report
- September 2025
- 150 Pages
Global
From €5383EUR$5,950USD£4,609GBP
- Report
- June 2026
- 198 Pages
Global
From €3207EUR$3,545USD£2,746GBP
€3563EUR$3,939USD£3,052GBP
- Report
- August 2025
- 189 Pages
Global
From €3207EUR$3,545USD£2,746GBP
€3563EUR$3,939USD£3,052GBP
- Report
- February 2026
- 250 Pages
Global
From €4062EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4062EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4062EUR$4,490USD£3,478GBP
- Report
- July 2026
- 374 Pages
Global
From €5292EUR$5,850USD£4,532GBP

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists.
Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more